Literature DB >> 28090530

CK1δ: an exploitable vulnerability in breast cancer.

Laura H Rosenberg1, John L Cleveland2, William R Roush3, Derek R Duckett4.   

Abstract

Entities:  

Year:  2016        PMID： 28090530      PMCID： PMC5220019          DOI： 10.21037/atm.2016.12.15

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  13 in total

1.  Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15.

Authors:  N Dumaz; D M Milne; D W Meek
Journal:  FEBS Lett       Date:  1999-12-17       Impact factor: 4.124

2.  Casein kinase 1δ-dependent Wee1 protein degradation.

Authors:  Clara Penas; Vimal Ramachandran; Scott Simanski; Choogon Lee; Franck Madoux; Ronald J Rahaim; Ruchi Chauhan; Omar Barnaby; Stephan Schurer; Peter Hodder; Judith Steen; William R Roush; Nagi G Ayad
Journal:  J Biol Chem       Date:  2014-05-09       Impact factor: 5.157

3.  Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.

Authors:  Srinivas Malladi; Danilo G Macalinao; Xin Jin; Lan He; Harihar Basnet; Yilong Zou; Elisa de Stanchina; Joan Massagué
Journal:  Cell       Date:  2016-03-24       Impact factor: 41.582

4.  Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase.

Authors:  Hiroyuki Inuzuka; Alan Tseng; Daming Gao; Bo Zhai; Qing Zhang; Shavali Shaik; Lixin Wan; Xiaolu L Ang; Caroline Mock; Haoqiang Yin; Jayne M Stommel; Steven Gygi; Galit Lahav; John Asara; Zhi-Xiong Jim Xiao; William G Kaelin; J Wade Harper; Wenyi Wei
Journal:  Cancer Cell       Date:  2010-08-09       Impact factor: 31.743

5.  β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.

Authors:  Babette Schade; Robert Lesurf; Virginie Sanguin-Gendreau; Tung Bui; Geneviève Deblois; Sandra A O'Toole; Ewan K A Millar; Sara J Zardawi; Elena Lopez-Knowles; Robert L Sutherland; Vincent Giguère; Michael Kahn; Michael Hallett; William J Muller
Journal:  Cancer Res       Date:  2013-05-29       Impact factor: 12.701

6.  Therapeutic targeting of casein kinase 1δ in breast cancer.

Authors:  Laura H Rosenberg; Marie Lafitte; Victor Quereda; Wayne Grant; Weimin Chen; Mathieu Bibian; Yoshihiko Noguchi; Mohammad Fallahi; Chunying Yang; Jenny C Chang; William R Roush; John L Cleveland; Derek R Duckett
Journal:  Sci Transl Med       Date:  2015-12-16       Impact factor: 17.956

7.  Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties.

Authors:  Mathieu Bibian; Ronald J Rahaim; Jun Yong Choi; Yoshihiko Noguchi; Stephan Schürer; Weimin Chen; Shima Nakanishi; Konstantin Licht; Laura H Rosenberg; Lin Li; Yangbo Feng; Michael D Cameron; Derek R Duckett; John L Cleveland; William R Roush
Journal:  Bioorg Med Chem Lett       Date:  2013-05-31       Impact factor: 2.823

8.  PORCN moonlights in a Wnt-independent pathway that regulates cancer cell proliferation.

Authors:  Tracy M Covey; Simran Kaur; Tina Tan Ong; Kyle D Proffitt; Yonghui Wu; Patrick Tan; David M Virshup
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

9.  WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.

Authors:  Yutaka Matsuda; Thomas Schlange; Edward J Oakeley; Anne Boulay; Nancy E Hynes
Journal:  Breast Cancer Res       Date:  2009-05-27       Impact factor: 6.466

10.  Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.

Authors:  Thomas Schlange; Yutaka Matsuda; Susanne Lienhard; Alexandre Huber; Nancy E Hynes
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.